{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:07:33Z","timestamp":1769598453521,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00423-021-02279-6","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T04:02:38Z","timestamp":1626753758000},"page":"2449-2456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used"],"prefix":"10.1007","volume":"406","author":[{"given":"\u00c1lvaro Jes\u00fas","family":"G\u00f3mez-Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alida","family":"Gonz\u00e1lez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-0312","authenticated-orcid":false,"given":"Felipe","family":"Alconchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Navarro-Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gil-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jer\u00f3nimo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u00edbal","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Garc\u00eda-Palenciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Antonio","family":"Cascales-Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"2279_CR1","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2019) SEER cancer statistics review, 1975\u20132016. National Cancer Institute, Bethesda. Based on November 2018 SEER data submission, posted to the SEER web site. https:\/\/seer.cancer.gov\/csr\/1975_2016\/"},{"key":"2279_CR2","first-page":"1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK et al (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Orthod 20:1248\u20131259","journal-title":"J Clin Orthod"},{"issue":"1","key":"2279_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1272\/jnms.67.5","volume":"67","author":"PH Sugarbaker","year":"2000","unstructured":"Sugarbaker PH (2000) It\u2019s what the surgeon doesn\u2019t see that kills the patient. J Nippon Med Sch 67(1):5\u20138","journal-title":"J Nippon Med Sch"},{"key":"2279_CR4","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","volume":"335","author":"DS Alberts","year":"1996","unstructured":"Alberts DS, Liu PY, Hannigan EV et al (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335:1950\u20131955","journal-title":"N Engl J Med"},{"key":"2279_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"M Markman","year":"2001","unstructured":"Markman M, Bundy BN, Alberts DS et al (2001) Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 19:1001\u20131007","journal-title":"J Clin Oncol"},{"key":"2279_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"issue":"3","key":"2279_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378(3):230\u2013240","journal-title":"N Engl J Med"},{"issue":"5","key":"2279_CR8","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","volume":"22","author":"J Spiliotis","year":"2015","unstructured":"Spiliotis J, Halkia E, Lianos E et al (2015) Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 22(5):1570\u20131575","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"2279_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ygyno.2018.09.007","volume":"151","author":"O Zivanovic","year":"2018","unstructured":"Zivanovic O, Chi DS, Filippova O et al (2018) It\u2019s time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer. Gynecol Oncol 151(3):555\u2013561","journal-title":"Gynecol Oncol"},{"key":"2279_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","volume":"22","author":"J Spiliotis","year":"2015","unstructured":"Spiliotis J, Halkia E, Lianos E et al (2015) Cytoreductive surgery and HIPEC in re- current epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 22:1570\u20131575","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2279_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/02656736.2017.1293304","volume":"33","author":"EI-L Sin","year":"2017","unstructured":"Sin EI-L, Chia CS, Tan GHC et al (2017) Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Int J Hyperth 33(6):690\u20135","journal-title":"Int J Hyperth"},{"key":"2279_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:204\u2013212","journal-title":"Crit Care"},{"key":"2279_CR13","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network. Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31","journal-title":"Crit Care"},{"issue":"3","key":"2279_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.suronc.2016.05.010","volume":"25","author":"P Cascales-Campos","year":"2016","unstructured":"Cascales-Campos P, L\u00f3pez-L\u00f3pez V, Gil J et al (2016) Hyperthermic intraperitoneal chemotherapy with paclitaxel or cisplatin in patients with stage III-C\/IV ovarian cancer. Is there any difference? Surg Oncol 25(3):164\u201370","journal-title":"Surg Oncol"},{"issue":"3","key":"2279_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1245\/s10434-014-4049-z","volume":"22","author":"PA Cascales-Campos","year":"2015","unstructured":"Cascales-Campos PA, Gil J, Feliciangeli E et al (2015) The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction. Ann Surg Oncol 22(3):987\u2013993","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2279_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221(2):124\u201332","journal-title":"Ann Surg"},{"issue":"1","key":"2279_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29\u201342","journal-title":"Ann Surg"},{"key":"2279_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/01.ASN.0000130340.93930.DD","volume":"15","author":"A Lassnigg","year":"2004","unstructured":"Lassnigg A, Schmidlin D, Mouhieddine M et al (2004) Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597\u20131605","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2279_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ejso.2015.08.174","volume":"42","author":"M Ceresoli","year":"2016","unstructured":"Ceresoli M, Coccolini F, Ansaloni L (2016) HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol 42(6):909\u2013910","journal-title":"Eur J Surg Oncol"},{"key":"2279_CR20","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow GM, Burdick E, Honour M et al (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365\u20133370","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2279_CR21","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s00134-009-1530-4","volume":"35","author":"M Joannidis","year":"2009","unstructured":"Joannidis M, Metnitz B, Bauer P et al (2009) Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 35(10):1692\u20131702","journal-title":"Intensive Care Med"},{"issue":"8","key":"2279_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1245\/ASO.2003.01.018","volume":"10","author":"O Glehen","year":"2003","unstructured":"Glehen O, Osinsky D, Cotte E et al (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10(8):863\u2013869","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2279_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ejso.2015.12.016","volume":"42","author":"A Arjona-S\u00e1nchez","year":"2016","unstructured":"Arjona-S\u00e1nchez A, Cadenas-Febres A, Cabrera-Bermon J, Mu\u00f1oz-Casares FC, Casado-Adam A, S\u00e1nchez-Hidalgo JM et al (2016) Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances. Eur J Surg Oncol 42(6):869\u2013876","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"2279_CR24","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/02656736.2017.1368096","volume":"34","author":"JP Cata","year":"2018","unstructured":"Cata JP, Zavala AM, Meter AV, Williams UU, Soliz J, Hernandez M et al (2018) Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study. Int J Hyperth 34(5):538\u2013544","journal-title":"Int J Hyperth"},{"issue":"2","key":"2279_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/0265673021000035235","volume":"19","author":"M Takemoto","year":"2003","unstructured":"Takemoto M, Kuroda M, Urano M et al (2003) The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumors. Int J Hyperthermia 19(2):193\u2013203","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"2279_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00228-012-1405-4","volume":"69","author":"PH Cashin","year":"2013","unstructured":"Cashin PH, Ehrsson H, Wallin I et al (2013) Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis. Eur J Clin Pharmacol 69(3):533\u2013540","journal-title":"Eur J Clin Pharmacol"},{"key":"2279_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0091270009360980","volume":"51","author":"E Cotte","year":"2011","unstructured":"Cotte E, Colomban O, Guitton J et al (2011) Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitonealchemotherapy using a closed abdominal procedure. J Clin Pharmacol 51:9\u201318","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"2279_CR28","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3109\/0886022X.2014.949758","volume":"36","author":"HA Hakeam","year":"2014","unstructured":"Hakeam HA, Breakiet M, Azzam A, Nadeem A, Amin T (2014) The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail 36(10):1486\u20131491","journal-title":"Ren Fail"},{"issue":"1","key":"2279_CR29","first-page":"492","volume":"36","author":"R Kapoor","year":"2019","unstructured":"Kapoor R, Robinson KA, Cata JP, Owusu-Agyemang P, Soliz JM, Hernandez M et al (2019) Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy. Null 36(1):492\u20137","journal-title":"Null"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02279-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-021-02279-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02279-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T18:09:21Z","timestamp":1636481361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-021-02279-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2279"],"URL":"https:\/\/doi.org\/10.1007\/s00423-021-02279-6","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has the approval of the clinical research ethics committee and the written consent of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}